Steven Cohen’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,175
| Closed | -$1.48M | – | 4489 |
|
|
2026
Q1 | $1.68M | Sell |
2,175
-260,352
| -99% | -$199M | ﹤0.01% | 2436 |
|
|
2025
Q4 | $203M | Buy |
262,527
+61,028
| +30% | +$41.4M | 0.23% | 52 |
|
|
2025
Q3 | $113M | Buy |
201,499
+58,391
| +41% | +$33M | 0.19% | 105 |
|
|
2025
Q2 | $75.1M | Buy |
+143,108
| New | +$79.9M | 0.15% | 164 |
|
|
2024
Q3 | – | Sell |
-22,871
| Closed | -$25.5M | – | 2279 |
|
|
2024
Q2 | $24M | Buy |
+22,871
| New | +$22.2M | 0.06% | 356 |
|
|
2023
Q4 | – | Sell |
-1,407
| Closed | -$1.16M | – | 2702 |
|
|
2023
Q3 | $1.16M | Buy |
+1,407
| New | +$1.11M | ﹤0.01% | 1284 |
|
|
2021
Q3 | – | Sell |
-188,700
| Closed | -$105M | – | 1206 |
|
|
2021
Q2 | $105M | Buy |
+188,700
| New | +$95.6M | 0.47% | 35 |
|
|
2020
Q3 | – | Sell |
-53,609
| Closed | -$33.4M | – | 1070 |
|
|
2020
Q2 | $33.4M | Buy |
+53,609
| New | +$30.4M | 0.22% | 128 |
|
|
2019
Q4 | – | Sell |
-440,940
| Closed | -$122M | – | 1204 |
|
|
2019
Q3 | $122M | Sell |
440,940
-42,905
| -9% | -$12.7M | 0.75% | 19 |
|
|
2019
Q2 | $151M | Buy |
+483,845
| New | +$161M | 0.79% | 17 |
|
|
2019
Q1 | – | Sell |
-168,644
| Closed | -$63M | – | 1195 |
|
|
2018
Q4 | $63M | Buy |
+168,644
| New | +$61.7M | 0.31% | 89 |
|
|
2018
Q3 | – | Sell |
-27,700
| Closed | -$9.56M | – | 1190 |
|
|
2018
Q2 | $9.56M | Sell |
27,700
-171,400
| -86% | -$53.6M | 0.04% | 451 |
|
|
2018
Q1 | $68.6M | Sell |
199,100
-282,254
| -59% | -$98.2M | 0.29% | 95 |
|
|
2017
Q4 | $181M | Buy |
+481,354
| New | +$195M | 0.78% | 15 |
|
|
2017
Q2 | – | Sell |
-70,000
| Closed | -$27.1M | – | 978 |
|
|
2017
Q1 | $27.1M | Buy |
+70,000
| New | +$25.9M | 0.15% | 186 |
|
|
2016
Q2 | – | Sell |
-109,700
| Closed | -$39.5M | – | 849 |
|
|
2016
Q1 | $39.5M | Buy |
+109,700
| New | +$45.2M | 0.3% | 81 |
|
|
2014
Q4 | – | Sell |
-23,600
| Closed | -$8.51M | – | 774 |
|
|
2014
Q3 | $8.51M | Buy |
23,600
+9,100
| +63% | +$3.05M | 0.06% | 307 |
|
|
2014
Q2 | $4.1M | Buy |
+14,500
| New | +$4.3M | 0.03% | 487 |
|
Other funds holding REGN
Steven Cohen's REGN Position: Q2 2026 in Review
Steven Cohen sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 2,175 shares — an estimated $1.48M sold.
Steven Cohen first reported a position in REGN in Q2 2014 and held it in 18 quarters. The position peaked at $203M in Q4 2025. 1,328 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Steven Cohen reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Steven Cohen sold 2,175 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.48M.
- Steven Cohen first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 18 quarters.
- Steven Cohen's Regeneron Pharmaceuticals position peaked at $203M in Q4 2025.
- 1,328 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.